AFFY,ATHX,BDMS,CRMB,CTIC,GLBS,GTAT,HIMX,IGOI,INBK,JACQ,LIVE,MCOX,MGCD,PAMT,PLMT,PRTS,RIVR,RPRX,RPRXW,RPRXZ,SANWW,TFCO,TSRI,ZIONW -

. Currency in USD
Stock chart is not supported by your current browser
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
VolumeN/A
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters2 hours ago

    Tiny stem cell companies close in on major heart disease goals

    The early hope that stem cell therapy would make the paralyzed walk, the blind see and cure diabetes have given way to a long list of failures, highlighted by early stem cell champion Geron Corp abandoning the field in 2011. Both have overcome major hurdles to manufacturing stem cell treatments on a large scale that are off-the-shelf products derived from healthy donor bone marrow and do not face immune system rejection issues. Cleveland-based Athersys, with a market value of about $200 million, demonstrated evidence in a midstage trial that its therapy may be able to expand the emergency treatment window for major strokes to up to 36 hours, compared with about four hours with current drugs, potentially allowing many more patients to avoid crippling disabilities.

  • At $2.46, Is US Auto Parts Network Inc (NASDAQ:PRTS) A Buy?
    Simply Wall St.3 days ago

    At $2.46, Is US Auto Parts Network Inc (NASDAQ:PRTS) A Buy?

    US Auto Parts Network Inc (NASDAQ:PRTS), a online retail company based in United States, saw a significant share price rise of over 20% in the past couple of months onRead More...

  • Does CTI BioPharma Corp’s (NASDAQ:CTIC) Past Performance Indicate A Stronger Future?
    Simply Wall St.3 days ago

    Does CTI BioPharma Corp’s (NASDAQ:CTIC) Past Performance Indicate A Stronger Future?

    Improvement in profitability and outperformance against the industry can be important characteristics in a stock for some investors. Below, I will assess CTI BioPharma Corp’s (NASDAQ:CTIC) track record on aRead More...

  • Capital Cube4 days ago

    ETFs with exposure to U.S. Auto Parts Network, Inc. : December 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to U.S. Auto Parts Network, Inc. Here are 5 ETFs with the largest exposure to PRTS-US. Comparing the performance and risk of U.S. Auto Parts Network, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns ... Read more (Read more...)

  • Allergan Inks Deal to Buy Texas-Based Repros Therapeutics
    Zacks4 days ago

    Allergan Inks Deal to Buy Texas-Based Repros Therapeutics

    Allergan (AGN) signs a definitive contract to acquire Texas-based Repros Therapeutics, which is focused on developing new drugs to treat hormonal and reproductive system disorders.

  • Capital Cube6 days ago

    ETFs with exposure to Live Ventures, Inc. : December 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Live Ventures, Inc. Here are 5 ETFs with the largest exposure to LIVE-US. Comparing the performance and risk of Live Ventures, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Why Himax Technologies, Inc. Popped 34% in November
    Motley Fool6 days ago

    Why Himax Technologies, Inc. Popped 34% in November

    Investors started believing in Himax's growth story again after it beat analysts' estimates in the third quarter.

  • American City Business Journals6 days ago

    Allergan to buy Woodlands-based drug company

    Pharmaceutical giant Allergan PLC (AGN) will acquire The Woodlands-based Repros Therapeutics Inc. (RPRX), a company that develops drugs to treat male and female reproductive disorders, according to a Dec. 12 press release. A subsidiary of Ireland-based Allergan will purchase all of the outstanding shares of Repros common stock through a cash tender offer for 67 cents per share. Allergan — formerly Actavis PLC — reported net revenue of $14.57 billion in 2016, according to its annual report.

  • With 11% Earnings Growth Lately, Did First Internet Bancorp (undefined:INBK) Outperform The Industry?
    Simply Wall St.6 days ago

    With 11% Earnings Growth Lately, Did First Internet Bancorp (undefined:INBK) Outperform The Industry?

    Today I will take a look at First Internet Bancorp’s (NASDAQ:INBK) most recent earnings update (30 September 2017) and compare these latest figures against its performance over the past fewRead More...

  • Who Owns Most Of Repros Therapeutics Inc (RPRX)?
    Simply Wall St.9 days ago

    Who Owns Most Of Repros Therapeutics Inc (RPRX)?

    Today, I will be analyzing Repros Therapeutics Inc’s (NASDAQ:RPRX) recent ownership structure, an important but not-so-popular subject among individual investors. When it comes to ownership structure of a company, theRead More...

  • Where Globus Maritime Limited (GLBS) Stands In Terms Of Earnings Growth Against Its Industry
    Simply Wall St.11 days ago

    Where Globus Maritime Limited (GLBS) Stands In Terms Of Earnings Growth Against Its Industry

    When Globus Maritime Limited’s (NASDAQ:GLBS) announced its latest earnings (30 June 2017), I wanted to understand how these figures stacked up against its past performance. The two benchmarks I usedRead More...

  • All You Need To Know About Himax Technologies Inc’s (HIMX) Financial Health
    Simply Wall St.11 days ago

    All You Need To Know About Himax Technologies Inc’s (HIMX) Financial Health

    Small-caps and large-caps are wildly popular among investors, however, mid-cap stocks, such as Himax Technologies Inc (NASDAQ:HIMX) with a market capitalization of $2.29B, rarely draw their attention from analysts andRead More...

  • Why Shares of Himax Technologies Tumbled Today
    Motley Fool11 days ago

    Why Shares of Himax Technologies Tumbled Today

    A nasty tweet from Citron Research contributed to the stock's decline.

  • Why Tronox, OSI Systems, and Himax Technologies Slumped Today
    Motley Fool11 days ago

    Why Tronox, OSI Systems, and Himax Technologies Slumped Today

    Find out which of these stocks had to deal with negative comments from analysts.

  • 3 Growth Stocks for in-the-Know Investors
    Motley Fool13 days ago

    3 Growth Stocks for in-the-Know Investors

    If you don't know, now you know.

  • SmarterAnalyst13 days ago

    Himax Is Not Looking Too Hot for 2018, Says Rosenblatt

    Himax Technologies (NASDAQ:HIMX) is a semiconductor company that may have met its match: lackluster 3D sensing revenue just around the corner. Rosenblatt analyst Jun Zhang is a bear anticipating roughly 54% downside potential for the Taiwanese fabless semiconductor firm that he believes simply cannot live up to its own 3D sensing revenue expectations in 2018.

  • Here’s Why Patience Should Pay Off for Himax Technologies Investors
    Motley Fool15 days ago

    Here’s Why Patience Should Pay Off for Himax Technologies Investors

    Himax Technologies investors aren't panicking despite a mixed showing last quarter.

  • 3 Growth Stocks for Successful Investors
    Motley Fool17 days ago

    3 Growth Stocks for Successful Investors

    These three companies have what it takes to win in the future.

  • GuruFocus.com17 days ago

    Is Himax Technologies a Buy?

    The chipmaker's journey is just getting started

  • SmarterAnalyst18 days ago

    Roth Capital Gets Even More Bullish on Himax Pointing to Stable iPhone Demand for 4Q

    Roth Capital analyst Suji Desilva is bumping up the assurance factor when it comes to Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) and its opportunity as a "differentiated investment." The Taiwanese fabless semiconductor firm is already tracking past the analyst's prior estimate for the fourth quarter, leading Desilva to rev up his price target and look forward with confidence to a 3D sensing-centered 2018 primed for growth.

  • Why Himax Technologies, Inc. Could Be a Gold Mine for Growth Investors
    Motley Fool18 days ago

    Why Himax Technologies, Inc. Could Be a Gold Mine for Growth Investors

    With supply issues addressed and an industry-leading technology ready for customers, the display driver upstart is poised to grow.

  • How Does Investing In Repros Therapeutics Inc (RPRX) Impact Your Portfolio?
    Simply Wall St.18 days ago

    How Does Investing In Repros Therapeutics Inc (RPRX) Impact Your Portfolio?

    For Repros Therapeutics Inc’s (NASDAQ:RPRX) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. RPRX is exposedRead More...

  • MarketWatch19 days ago

    Harry Boxer’s four stocks breaking out, including Winnebago

    Also in focus: Energy Recovery, Himax Technologies and Remark Holdings.

  • Benzinga19 days ago

    Vetr Turns Bullish On Himax As Stock Pushes For New Highs

    The Vetr crowd on Tuesday upgraded its rating on Himax Technologies, Inc. (NASDAQ: HIMX ) from 1.5 stars (Strong Sell), issued four days ago, to 4.5 stars (Strong Buy). Crowd sentiment at the time of the ...

  • Top NasdaqGS High Growth Stock
    Simply Wall St.20 days ago

    Top NasdaqGS High Growth Stock

    Companies that have significant growth prospects for profitability and returns can add tangible upside to your portfolio. Himax Technologies and Eco-Stim Energy Solutions are examples of many potential outperformers thatRead More...